the word how important the monoclonal antibodies are. but when we started seeing the omicron variant in south africa, right, just at the very beginning, at soon as it got reported, no evidence in the united states, we looked at the molecular biology and did our analysis of those mutations and realized that two of the three monoclonal antibodies were not going to work. we used our best science and recognized that the regeneron and the lilly were not going to work, but there was still plenty of delta. we made sure people use that, but we pulled back for a number of weeks the gsk vir monoclonal. that allowed to us have more we shipped out this last week, we are shipping out more.